Literature DB >> 2328491

Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.

D D Ross1, S R Chen, D P Cuddy.   

Abstract

The pH-step alkaline elution method enables the isolation and quantification of nascent DNA (nDNA) replication intermediates, including Okazaki fragments, short length nDNA from replicon origins, longer lengths of nascent but subgenomic length nDNA (molecular weight, 20-30 x 10(6)), and full (or genomic) length nDNA (L. C. Erickson et al., Chromosoma, 74: 125-139, 1979). We utilized this technique to study, in HL-60 cells, the effects of 1-beta-D-arabinofuranosylcytosine (ara-C) on the formation of these replication intermediates and the kinetics of transit of radiolabel from [3H]thymidine ([3H]dThd) or [3H]-ara-C through these nDNA fragments and into full length nDNA. In the continuous presence of [3H]-ara-C (4 microM), the majority of radiolabel (greater than 85%) remained in the nascent subgenomic fractions, with 30-50% remaining in Okazaki fragments. These proportions did not change substantially with increasing time of exposure to [3H]-ara-C (from 1 to 24 h), although the total amount of [3H]-ara-C incorporated into DNA continued to increase with increasing time of exposure. In contrast, when cells were exposed to [3H]-ara-C for 1 h, placed in drug-free medium, and studied by the pH-step method at various times thereafter, the transit of radiolabel through progressively larger nDNA intermediates and into full length nDNA was rapid and equal to that of [3H]dThd in cells not exposed to drug. The observed elution of [3H]-ara-C in the subgenomic-length DNA fragments was not due to ara-C-induced breaks in template (parental) DNA and subsequent incorporation of [3H]-ara-C into the template strand, since ara-C treatment of cells prelabeled with [14C]dThd failed to cause substantial elution of the 14C label at the various pH steps used. In studies of the effects of ara-C on [3H]dThd incorporation into nDNA, concentrations of 1 to 10 microM ara-C inhibited total incorporation of radiolabel into DNA by greater than 90% and incorporation into full length nDNA by greater than 97%. In contrast, these concentrations of ara-C failed to decrease the amount of [3H]dThd incorporated into Okazaki fragments or other non-mitochondrial low molecular weight nDNA, compared to control. These studies demonstrate that, in HL-60 cells, ara-C causes profound inhibition of nascent chain elongation, does not cause chain termination, and does not inhibit initiation. In fact, ara-C may stimulate initiation, leading credence to recent theories proposing endoreduplication or reinitiation as consequences of ara-C incorporation into DNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328491

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.

Authors:  D D Ross; D P Cuddy; N Cohen; D R Hensley
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.

Authors:  Sanduni U Liyanage; Rose Hurren; Veronique Voisin; Gaëlle Bridon; Xiaoming Wang; ChangJiang Xu; Neil MacLean; Thirushi P Siriwardena; Marcela Gronda; Dana Yehudai; Shrivani Sriskanthadevan; Daina Avizonis; Aisha Shamas-Din; Mark D Minden; Gary D Bader; Rebecca Laposa; Aaron D Schimmer
Journal:  Blood       Date:  2017-03-10       Impact factor: 22.113

3.  Adipose-derived stem cells retain their regenerative potential after methotrexate treatment.

Authors:  Olivia S Beane; Vera C Fonseca; Eric M Darling
Journal:  Exp Cell Res       Date:  2014-06-30       Impact factor: 3.905

4.  Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.

Authors:  Andries M Bergman; Auke D Adema; Jan Balzarini; Skjalg Bruheim; Iduna Fichtner; Paul Noordhuis; Oystein Fodstad; Finn Myhren; Marit L Sandvold; Hans R Hendriks; Godefridus J Peters
Journal:  Invest New Drugs       Date:  2010-01-12       Impact factor: 3.850

5.  DNA repair mechanisms in cancer development and therapy.

Authors:  Alessandro Torgovnick; Björn Schumacher
Journal:  Front Genet       Date:  2015-04-23       Impact factor: 4.599

6.  Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η.

Authors:  Olga Rechkoblit; Robert E Johnson; Angeliki Buku; Louise Prakash; Satya Prakash; Aneel K Aggarwal
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

7.  Determinants of trimetrexate lethality in human colon cancer cells.

Authors:  J L Grem; D M Voeller; F Geoffroy; E Horak; P G Johnston; C J Allegra
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

8.  Enhancement of cytosine arabinoside cytotoxicity by granulocyte/macrophage colony-stimulating factor and granulocyte colony-stimulating factor in a human myeloblastic leukemia cell line.

Authors:  R Takauji; K Tohyama; T Ueda; T Nakamura
Journal:  Jpn J Cancer Res       Date:  1993-04

Review 9.  Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism.

Authors:  Nikolaos Tsesmetzis; Cynthia B J Paulin; Sean G Rudd; Nikolas Herold
Journal:  Cancers (Basel)       Date:  2018-07-23       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.